# Respiratory System & Pulmonology

## Respiratory Tract Embryology Stages {EPCSA}

- Embryonic
- Pseudoglandular
- Canalicular
- Saccular
- Alveolar

## Lung Volumes and Measurements

|Indices|Methods|
|-|-|
|IRV & TV & ERV|Spirometry|
|RV|Helium dilution method & Plethysmography|

![](../Figures/Lung%20Volumes.png)

## Perfusion and Diffusion Limited Pulmonary Circulation

![](../Figures/Perfusion%20and%20Diffusion%20Limited%20Pulmonary%20Circulation.png)

## Ventilation/Perfusion (V/Q) Ratio

|Ratio|Conditions|
|-|-|
|0|Shunt|
|Low|Lung base|
|High|Lung apex|
|∞|Dead space|

### Shunt (↓ V/Q)

- Anatomic shunt (↑ Q)
  - Intracardiac shunt
  - Pulmonary arteriovenous malformation (AVM)
  - Hepatopulmonary syndrome
- Physiologic shunt (↓ V)
  - Obstructive lung diseases
  - Alveolar lung diseases

### Dead Space (↑ V/Q)

- Pulmonary embolism
- Pulmonary vascular diseases

## Etiology of Increased A-a Gradient

- Interstitial lung diseases
- V/Q mismatch

## Breathing Patterns

![](../Figures/Respiratory%20Patterns.png)

## Etiology of Kussmaul Breathing {KUSSMAUL}

- Ketoacidosis
- Uremia
- Sepsis
- Salicylate
- Methanol
- Aldehyde
- Uricemia
- Lactic acidosis

## Light Criteria for Pleural Fluid (PF)

|PF|PF ÷ Serum Protein|PF ÷ Serum LDH|PF LDH|
|-|-|-|-|
|Transudate|< 0.5|< 0.6|< 2/3 Serum LDH upper limit|
|Exudate|> 0.5|> 0.6|> 2/3 Serum LDH upper limit|

## Classification of Asthma Severity

|Asthma|Attacks|Awakenings|SABA Uses|FEV<sub>1</sub>|FEV<sub>1</sub>/FVC|
|-|-|-|-|-|-|
|Intermittent|< 2 days/week|≤ 2/month|≤ 2 days/week|> 80%|Normal|
|Mild persistent|2 ~ 7 days/week|3 ~ 4/month|2 ~ 7 days/week|> 80%|Normal|
|Moderate persistent|Daily|> 1/week|Daily|60 ~ 80%|↓ < 0.05|
|Severe persistent|Throughout|Daily|Throughout|< 60%|↓ > 0.05|

## GOLD Staging of Chronic Obstructive Pulmonary Disease (COPD)

|Stage|Severity|FEV<sub>1</sub>|
|-|-|-|
|1|Mild|> 80%|
|2|Moderate|50 ~ 80%|
|3|Severe|30 ~ 50%|
|4|Very severe|< 30%|

## Treatment of Asthma

![](../Figures/Treatment%20of%20Asthma.gif)

## Mechanisms of Action of Medications for Asthma

|Mechanism|Medication|Indications|
|-|-|-|
|β<sub>2</sub> agonists|Albuterol|Asthma :: acute|
||Salmeterol & Formoterol|Asthma :: chronic|
|M antagonists|Ipratropium & Tiotropium|Asthma|
|NF-κB inhibitors|Steroids|Asthma|
|LOX inhibitors|Zileuton|Asthma|
|LTD<sub>4</sub> antagonists|Montelukast|Asthma|
||Zafirlukast|Asthma|
|Mast cell inhibitors|Cromolyn|Asthma|
||Nedocromil|Asthma|
|IgE inhibitors|Omalizumab|Asthma|

## Types of Pneumoconioses

|Type|Deposit|Location|Findings|Associations|
|-|-|-|-|-|
|Asbestosis|Asbestos|Lung base|Calcified pleural plaques<br>Ferruginous bodies|Bronchogenic carcinoma<br>Mesothelioma|
|Coal worker’s disease|Coal dust|Lung apex|-|-|
|Silicosis|Silica|Lung apex|Eggshell calcifications|Tuberculosis|
|Berylliosis|Beryllium|Hilum|Hilar adenopathy|-|

## Types of Lung Cancers

|Type|Location|Paraneoplastic Syndromes|
|-|-|-|
|Small cell carcinoma|Central|ACTH & SIADH<br>Lambert-Eaton myasthenic syndrome<br>Paraneoplastic myelitis/encephalitis|
|Squamous cell carcinoma|Central|PTHrP|
|Adenocarcinoma|Peripheral|-|
|Large cell carcinoma|Peripheral|β-hCG|

## Modified Wells Criteria for Pulmonary Embolism

- Signs/symptoms of DVT
- PE is most likely clinical diagnosis
- Tachycardia
- Immobilization
- Previous PE/DVT
- Hemoptysis
- Malignancy

## Sputum Sample for Gram Stain

- PMNs > 25/HPF
- Epithelial cells < 10/HPF

## Pathogens of Bronchiolitis

- Adenovirus
- RSV
- Rhinovirus
- Coronavirus
- Parainfluenza virus
- Influenza virus

## Pathogens of Pneumonia

### Lobar Pneumonia & Bronchopneumonia

- Staphylococcus aureus
- Streptococcus pneumonia
- Haemophilus influenzae
- Klebsiella pneumoniae
- Pseudomonas aeruginosa
- Anaerobes
- Viruses

### Atypical Pneumonia {LCM}

- Legionella
- Chlamydia
- Mycoplasma

## CURB-65 Score for Pneumonia Severity

- Confusion
- Uremia :: BUN > 19
- Respiratory rate > 30
- Blood pressure :: SBP/DBP < 90/60 mm Hg
- Age > 65 years

## Empirical Antibiotics for Pneumonia

|Patient|Antibiotics|
|-|-|
|CAP & Uncomplicated|Amoxicillin<br>Macrolides / Doxycycline|
|CAP & Complicated|Amoxicillin & (Macrolides / Doxycycline)<br>Fluoroquinolones|
|CAP & Inpatient|Anti-pseudomonal β-lactams & (Macrolides / Doxycycline)<br>Fluoroquinolones|
|CAP & ICU|Anti-pseudomonal β-lactams & (Macrolides / Doxycycline / Fluoroquinolones)|
|HAP|Anti-pseudomonal β-lactams & (Aminoglycosides / Fluoroquinolones)|

### Complicated Patients

- Age > 65 years
- Antibiotics within 3 months
- Commorbid

## Respiratory Failure

|Type|PaO<sub>2</sub>|PaCO<sub>2</sub>|A-a Gradient|Etiology|
|-|-|-|-|-|
|1|↓|-|↑|V/Q mismatch|
|2|↓|↑|-|Hypoventilation|
|3|↓|↑|↑|Mixed|
|4|↓|↑|-|Sepsis|

## Ventilator Modes

|Sequence|Control|Trigger|Mode|
|-|-|-|-|
|Continuous mandatory|Presure (PC)<br>Volume (VC)|Time|Assist-control ventilation (ACV)|
|Intermittent mandatory|Presure (PC)<br>Volume (VC)|Time<br>Patient|Synchronized intermittent mandatory ventilation (SIMV)|
|Continuous spontaneous|-|Patient|Pressure support ventilation (PSV)|

## Ventilation Weaning Parameters

|Parameter|Normal Adult Range|Weaning Threshold|
|-|-|-|
|Respiratory Rate (RR)|14 ~ 18|< 40|
|Tidal Volume (V<sub>T</sub>)|5 ~ 7 mL/kg|5 mL/kg|
|Rapid shallow breathing index (RSBI) = RR ÷ V<sub>T</sub>|< 50/min/L|< 105/min/L|
|PF Ratio = PaO<sub>2</sub> ÷ FiO<sub>2</sub>|> 400|> 200|
|Max Inspiratory Pressure|< -90 cm H<sub>2</sub>O|< -25 cm H<sub>2</sub>O|
